Aprogen Pharmaceuticals Inc Cash Flow Reinvestment Rate
Aprogen Pharmaceuticals Inc cash flow reinvestment rate. Aprogen Pharmaceuticals Inc (003060) has a Cash Flow Reinvestment Rate of 1.29x as of December 2022, reinvesting ₩870.30 Million (capex ₩591.03 Million plus investments ₩-279.27 Million) from operating cash flow of ₩676.93 Million. Explore how well can Aprogen Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Aprogen Pharmaceuticals Inc (2010–2022)
Cash flow reinvestment rate of Aprogen Pharmaceuticals Inc from 2010 to 2022. Historical reinvestment intensity for Aprogen Pharmaceuticals Inc across 7 annual periods. Explore how much does Aprogen Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Aprogen Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2010–2022)
Aprogen Pharmaceuticals Inc cash flow reinvestment rate by year from 2010 to 2022. Year-by-year capital reinvestment analysis for Aprogen Pharmaceuticals Inc. For the full cash flow conversion analysis, see how efficiently does Aprogen Pharmaceuticals Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 2.12x | ₩54.55 Billion | ₩25.73 Billion | ₩1.55 Billion | ▼ -76.0% |
| 2020 | 8.84x | ₩71.48 Billion | ₩8.09 Billion | ₩976.29 Million | ▼ -85.4% |
| 2019 | 60.44x | ₩43.14 Billion | ₩713.73 Million | ₩2.13 Billion | ▲ +92.7% |
| 2018 | 31.37x | ₩41.77 Billion | ₩1.33 Billion | ₩1.01 Billion | ▼ -63.2% |
| 2016 | 85.22x | ₩38.35 Billion | ₩449.98 Million | ₩2.82 Billion | ▲ +733.9% |
| 2015 | 10.22x | ₩18.88 Billion | ₩1.85 Billion | ₩5.37 Billion | ▼ -79.4% |
| 2010 | 49.52x | ₩12.28 Billion | ₩247.92 Million | ₩12.28 Billion | — |